IGC Pharma (IGC) Receivables (2016 - 2025)
Historic Receivables for Pharma (IGC) over the last 17 years, with Q3 2025 value amounting to $711000.0.
- Pharma's Receivables fell 246.91% to $711000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $711000.0, marking a year-over-year decrease of 246.91%. This contributed to the annual value of $714000.0 for FY2025, which is 151.72% down from last year.
- Per Pharma's latest filing, its Receivables stood at $711000.0 for Q3 2025, which was down 246.91% from $767000.0 recorded in Q2 2025.
- In the past 5 years, Pharma's Receivables registered a high of $1.2 million during Q2 2023, and its lowest value of $493000.0 during Q1 2022.
- In the last 5 years, Pharma's Receivables had a median value of $725000.0 in 2024 and averaged $764947.4.
- Per our database at Business Quant, Pharma's Receivables soared by 13473.05% in 2023 and then tumbled by 3928.57% in 2024.
- Over the past 5 years, Pharma's Receivables (Quarter) stood at $546000.0 in 2021, then surged by 83.52% to $1.0 million in 2022, then grew by 3.59% to $1.0 million in 2023, then decreased by 29.87% to $728000.0 in 2024, then decreased by 2.34% to $711000.0 in 2025.
- Its last three reported values are $711000.0 in Q3 2025, $767000.0 for Q2 2025, and $714000.0 during Q1 2025.